BR112022020334A2 - Melhorador da qualidade do sono - Google Patents

Melhorador da qualidade do sono

Info

Publication number
BR112022020334A2
BR112022020334A2 BR112022020334A BR112022020334A BR112022020334A2 BR 112022020334 A2 BR112022020334 A2 BR 112022020334A2 BR 112022020334 A BR112022020334 A BR 112022020334A BR 112022020334 A BR112022020334 A BR 112022020334A BR 112022020334 A2 BR112022020334 A2 BR 112022020334A2
Authority
BR
Brazil
Prior art keywords
quality improvement
sleep quality
sleep
quality
ingestion
Prior art date
Application number
BR112022020334A
Other languages
English (en)
Portuguese (pt)
Inventor
Yamasaki Satomi
Kawaguchi Kazuhiko
Mizuno Takanori
Sakurai Tetsuya
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of BR112022020334A2 publication Critical patent/BR112022020334A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/032—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112022020334A 2020-04-14 2021-04-13 Melhorador da qualidade do sono BR112022020334A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020072192 2020-04-14
JP2020123385 2020-07-20
PCT/JP2021/015273 WO2021210565A1 (ja) 2020-04-14 2021-04-13 睡眠の質の改善剤

Publications (1)

Publication Number Publication Date
BR112022020334A2 true BR112022020334A2 (pt) 2022-11-22

Family

ID=78084866

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020334A BR112022020334A2 (pt) 2020-04-14 2021-04-13 Melhorador da qualidade do sono

Country Status (12)

Country Link
US (1) US20230149330A1 (https=)
EP (1) EP4137206A4 (https=)
JP (2) JPWO2021210565A1 (https=)
KR (1) KR20230005819A (https=)
CN (1) CN115397262A (https=)
AU (1) AU2021257176A1 (https=)
BR (1) BR112022020334A2 (https=)
CA (1) CA3175207A1 (https=)
IL (1) IL297227A (https=)
MX (1) MX2022012735A (https=)
PH (1) PH12022552709A1 (https=)
WO (1) WO2021210565A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4913410B1 (https=) 1970-05-29 1974-03-30
CN1172645A (zh) * 1997-07-18 1998-02-11 杨巍 柠檬酸盐溶石液及其制备方法
KR100379596B1 (ko) * 1999-09-13 2003-04-10 주식회사 한국팜비오 구연산칼륨을 주제로 한 요로결석치료제의 제조방법
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
KR20120120423A (ko) 2004-01-14 2012-11-01 아지노모토 가부시키가이샤 글리신을 함유하는 식품 및 이의 용도
EP1743633B1 (en) * 2004-04-06 2010-08-18 Taiyokagaku Co., Ltd. Use of a combination of theanine and serotonin for sleep disorders
JP2007230954A (ja) * 2006-03-02 2007-09-13 Fancl Corp 睡眠誘導剤及びストレス性不眠症改善剤
JP2009023948A (ja) * 2007-07-19 2009-02-05 Pokka Corp ドーパミン抑制剤
JP5282202B2 (ja) * 2008-04-11 2013-09-04 成都金麒麟生物健康科技有限公司 抗ストレス剤または睡眠改善剤
PL2712622T3 (pl) * 2008-05-21 2017-01-31 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
JP2014172892A (ja) * 2013-03-12 2014-09-22 Fujifilm Corp 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
MX352660B (es) * 2013-03-15 2017-12-04 Univ New York Bebida con contenido de citrato.
US20150087679A1 (en) * 2013-09-20 2015-03-26 Hany Helmi Nutritional sleep supplement
JP6976515B2 (ja) 2017-07-21 2021-12-08 国立大学法人 筑波大学 睡眠改善剤
JP7231898B2 (ja) 2018-09-26 2023-03-02 ビーエイチエヌ株式会社 睡眠の質改善剤
US20210369654A1 (en) * 2018-10-16 2021-12-02 Nippon Chemiphar Co., Ltd. Agent for improving quality of sleep
EP3868370A4 (en) * 2018-10-17 2022-06-29 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturia
JP7192399B2 (ja) 2018-10-31 2022-12-20 Tdk株式会社 薄膜キャパシタ
JP6815547B2 (ja) 2020-04-21 2021-01-20 株式会社フジタ 床振動解析プログラムおよび床振動解析装置

Also Published As

Publication number Publication date
IL297227A (en) 2022-12-01
CA3175207A1 (en) 2021-10-21
JP2025172167A (ja) 2025-11-20
PH12022552709A1 (en) 2024-04-22
AU2021257176A1 (en) 2022-11-10
EP4137206A4 (en) 2024-05-22
US20230149330A1 (en) 2023-05-18
KR20230005819A (ko) 2023-01-10
WO2021210565A1 (ja) 2021-10-21
CN115397262A (zh) 2022-11-25
EP4137206A1 (en) 2023-02-22
JPWO2021210565A1 (https=) 2021-10-21
MX2022012735A (es) 2022-11-07

Similar Documents

Publication Publication Date Title
Shehab et al. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus
Smith et al. Homocysteine–from disease biomarker to disease prevention
Soravia et al. Glucocorticoids enhance in vivo exposure‐based therapy of spider phobia
JOP20220179A1 (ar) N4-هيدروكسي سيتيدين ومشتقات واستخدامات مضادة للفيروسات مرتبطة بها
BR9711126A (pt) Medicamentos antiestresse e alimentos funcionais com efeitos antiestresse.
BR112022013280A2 (pt) Composição farmacêutica contendo regorafenib e um agente estabilizante
BR112012033457A2 (pt) formulações de anticorpo.
MA32018B1 (fr) Vaccin
Sashindran et al. Prevalence of Vitamin B12 deficiency in elderly population (> 60 years) presenting with dementia to outpatient department
BR112018074728A2 (pt) composições enterais altamente proteicas esterilizadas por calor com proteína do soro do leite que compreendem micelas de proteína do soro do leite e uma fonte de caseína
Schmitt et al. Nitrous oxide in pediatric anesthesia: friend or foe?
BR112022020334A2 (pt) Melhorador da qualidade do sono
Lu et al. Memantine depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism
Rossi-George et al. Copper disrupts S-nitrosothiol signaling in activated BV2 microglia
BR112022010269A2 (pt) Composições compreendendo oligossacarídeos de leite humano para uso em um indivíduo para suportar o desenvolvimento da linguagem
BR112022025220A2 (pt) Composição farmacêutica e artigo farmacêutico
WO2019046444A8 (en) Compositions and methods for diagnosing susceptibility to autism spectrum disorder (asd), reducing the likelihood of developing asd, and/or treating asd
Nittayananta et al. A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis‐free period in HIV infection
Hollis Vitamin D status during pregnancy: The importance of getting it right
CR20230223A (es) Composiciones farmacéuticas de un inhibidor de cinasa
MX2024012964A (es) Metodos y composiciones para retrasar el desarrollo de la diabetes o reducir el riesgo de la diabetes
BRPI0416461A (pt) método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
BR112021022388A2 (pt) Uso de micelas de proteína de soro de leite para controlar a resposta de glicose pós-prandial
Kokomoto et al. Current knowledge among pediatric dentistry specialists in Japan regarding prevention of infective endocarditis
BR112021026775A2 (pt) Processo para preparar uma composição que compreende um polipeptídeo de proteína d

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.